platinum has been researched along with Cardiotoxicity in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Ahn, S; Bao, K; Choi, HS; Kang, H; Kim, J; Park, SH; Stiles, WR; Yamashita, A; Zeng, L | 1 |
Cadeddu, C; Deidda, M; Demurtas, L; Madeddu, C; Mercuro, G; Piras, A; Piscopo, G; Puzzoni, M; Scartozzi, M | 1 |
1 review(s) available for platinum and Cardiotoxicity
Article | Year |
---|---|
Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy.
Topics: Anthracyclines; Anti-Bacterial Agents; Antineoplastic Agents, Alkylating; Cardiotoxicity; Fluorouracil; Heart Failure; Humans; Neoplasms; Oxidative Stress; Platinum; Stroke Volume; Taxoids; Ventricular Dysfunction, Left | 2016 |
1 other study(ies) available for platinum and Cardiotoxicity
Article | Year |
---|---|
H-Dot Mediated Nanotherapeutics Mitigate Systemic Toxicity of Platinum-Based Anticancer Drugs.
Topics: Animals; Antineoplastic Agents; Carboplatin; Cardiotoxicity; Cisplatin; Neoplasms; Platinum | 2023 |